scholarly article | Q13442814 |
P50 | author | Traci Rieckmann | Q47378631 |
P2093 | author name string | Dennis McCarty | |
Cindy P Thomas | |||
Bret E Fuller | |||
Marilyn Daley | |||
P2860 | cites work | A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network | Q24548339 |
Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings | Q33534318 | ||
The theory of planned behavior: a review of its applications to health-related behaviors | Q33573653 | ||
Pharmacological treatment of alcohol dependence: a review of the evidence | Q33596810 | ||
Drug therapy for alcohol dependence | Q33631182 | ||
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience | Q34081656 | ||
Effects of managed care on programs and practices for the treatment of alcohol and drug dependence. | Q34306362 | ||
Behavioral science and public health: a necessary partnership for HIV prevention | Q34405929 | ||
Buprenorphine for acute heroin detoxification: diffusion of research into practice | Q36738505 | ||
A range of research-based pharmacotherapies for addiction | Q41602489 | ||
Research to practice: adoption of naltrexone in alcoholism treatment | Q44368411 | ||
Staff beliefs about addiction treatment | Q47612604 | ||
Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. | Q51105478 | ||
Physicians' attitudes and retention of patients in their methadone maintenance programs. | Q51114221 | ||
Attitudes and beliefs of staff working in methadone maintenance clinics. | Q51115787 | ||
Alcoholic patients' experience and attitudes on pharmacotherapy for alcoholism. | Q52276448 | ||
Attitudes, beliefs and alcohol use. An analysis of relationships. | Q52282374 | ||
Normative and attitudinal control as moderating influences on marijuana use | Q67368977 | ||
Dispelling the myths about addiction: strategies to increase understanding and strengthen research | Q95433356 | ||
P433 | issue | 2 | |
P921 | main subject | opioid | Q427523 |
P304 | page(s) | 207-215 | |
P577 | publication date | 2006-12-08 | |
P1433 | published in | Journal of Substance Abuse Treatment | Q15762042 |
P1476 | title | Client and counselor attitudes toward the use of medications for treatment of opioid dependence | |
P478 | volume | 32 |
Q58165046 | A Perspective from the Field: The Disconnect between Abstinence-Based Programs and the Use of Motivational Interviewing in Treating Substance Use Disorders |
Q34503746 | A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients |
Q36364490 | A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment |
Q37498637 | A qualitative study of the adoption of buprenorphine for opioid addiction treatment |
Q34607338 | Adoption and implementation of medications in addiction treatment programs |
Q36806539 | Adoption of medications in substance abuse treatment: priorities and strategies of single state authorities |
Q33621921 | Attitudes toward buprenorphine and methadone among opioid-dependent individuals |
Q33576948 | Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program |
Q36522103 | Clinician attitudes, social norms and intentions to use a computer-assisted intervention |
Q37241381 | Clinician beliefs and attitudes about buprenorphine/naloxone diversion |
Q37199683 | Community-based addiction treatment staff attitudes about the usefulness of evidence-based addiction treatment and CBO organizational linkages to research institutions |
Q37087764 | Counselor attitudes toward and use of evidence-based practices in private substance use disorder treatment centers: a comparison of social workers and non-social workers |
Q36934945 | Counselor training and attitudes toward pharmacotherapies for opioid use disorder. |
Q34076189 | Diffusion of Contingency Management and Attitudes regarding Its Effectiveness and Acceptability |
Q34111054 | Facilitating Factors and Barriers to the Use of Medications in Publicly Funded Addiction Treatment Organizations |
Q35602408 | How do providers serving American Indians and Alaska Natives with substance abuse problems define evidence-based treatment? |
Q33776944 | Impact of research network participation on the adoption of buprenorphine for substance abuse treatment |
Q35400440 | Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio. |
Q37033705 | Improving acceptance of naltrexone in community addiction treatment centers: a pilot study |
Q39181057 | Incarcerated intravenous heroin users: predictors of post-release utilization of methadone maintenance treatment. |
Q34389080 | Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice |
Q44350841 | Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment |
Q52300834 | Messages about methadone and buprenorphine in reality television: a content analysis of celebrity rehab with Dr. Drew. |
Q42289728 | NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale |
Q36967059 | Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification |
Q39834450 | Perceptions Related to Pharmacological Treatment of Opioid Dependence Among Individuals Seeking Treatment at a Tertiary Care Center in Northern India: A Descriptive Study |
Q89792570 | Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders |
Q39739647 | Probation Staff Attitudes Toward Substance Abuse Treatment and Evidence-Based Practices |
Q33803543 | Racial and Ethnic Composition as a Correlate of Medication Availability within Addiction Treatment Organizations |
Q37224883 | Research on the diffusion of evidence-based treatments within substance abuse treatment: a systematic review |
Q33625968 | Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment |
Q44135207 | Substance use treatment counselors' attitudes toward evidence-based practice: the importance of organizational context |
Q89854785 | Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic |
Q35032811 | The impact of pay-for-performance on therapists' intentions to deliver high-quality treatment |
Q36364478 | The substance abuse counseling workforce: education, preparation, and certification |
Q35577449 | Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages |
Q35875486 | Treatment strategy profiles in substance use disorder treatment programs: A latent class analysis |
Q37115985 | Two Models of Integrating Buprenorphine Treatment and Medical Staff within Formerly "Drug-Free" Outpatient Programs |
Search more.